https://www.isct-cytotherapy.org/article/S1465-3249(23)00059-2/pdf
Old article- I had not read it- covers in depth potential therapies for aGvHD , all the trials conducted. Mentions Rem-l knocked back but still in commercial development.
I liked the bit where they say it would be good to get some long term results.
Reg
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-16147
-
- There are more pages in this discussion • 2,293 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B |
Open | High | Low | Value | Volume |
$1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 55197 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.53 | 29782 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 55197 | 1.525 |
2 | 7393 | 1.520 |
5 | 63970 | 1.515 |
7 | 88983 | 1.510 |
4 | 60982 | 1.505 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 28282 | 2 |
1.540 | 111981 | 9 |
1.545 | 118548 | 7 |
1.550 | 105230 | 23 |
1.555 | 640 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online